Article
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
3 Dec 2014
Abstract excerpt
BACKGROUND: Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options. METHODS: Using publicly available mRNA abundance datasets, we performed a large retrospective meta-analysis on 466 PDAC patients to discover prognostic gene signatures. These...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
